Trove
Sign In Sign Up

Relationship Details

Mr. Hugin → Executive company → Celgene
Back to Relationships

Connected Entities

Entity A
Mr. Hugin
Type: person
Mentions: 19
Entity B
Celgene
Type: person
Mentions: 0

Evidence

Mr. Hugin is described as a 'top executive' at Celgene who spoke on the company's behalf.

Mr. Hugin is described as a 'top executive' at Celgene who spoke on the company's behalf.

Mr. Hugin is described as a 'top executive' at Celgene who spoke on the company's behalf.

Source Documents (1)

HOUSE_OVERSIGHT_028419.jpg

Congressional Report/Oversight Document • 3.3 MB
View

This document, from a House Oversight file, details the business practices of the pharmaceutical company Celgene concerning its drugs Thalomid and Revlimid between 2000 and 2017. It outlines allegations of improper 'off-label' marketing, significant price increases, and aggressive strategies to extend its patent monopoly and block competition from generic drug makers. The document includes quotes from a Celgene executive, a federal regulatory agency, and a generic drug industry representative.

Mr. Hugin's Other Relationships

Employment Celgene
Strength: 7/10 View
Unknown Mr. Menendez
Strength: 6/10 View
Employee Celgene
Strength: 5/10 View
Political opponents Mr. Menendez
Strength: 5/10 View

Celgene's Other Relationships

Employment Mr. Hugin
Strength: 7/10 View
Regulatory oversight adversarial F.D.A.
Strength: 7/10 View
Regulated by F.D.A.
Strength: 6/10 View
Regulated entity regulator the agency
Strength: 6/10 View
Employee Bob Hugin
Strength: 5/10 View

Relationship Metadata

Type
Executive company
Relationship Strength
7/10
Strong relationship with substantial evidence
Source Documents
1
Extracted
2025-11-19 04:56
Last Updated
2025-11-19 04:57

Entity Network Stats

Mr. Hugin 5 relationships
Celgene 18 relationships
Mutual connections 0

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein relationship